Kyverna Therapeutics, Inc. (KYTX)
9.16
+0.50
(+5.77%)
USD |
NASDAQ |
Jan 14, 16:00
9.16
0.00 (0.00%)
After-Hours: 20:00
Kyverna Therapeutics Market Cap: 401.17M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.910B |
| CorMedix, Inc. | 558.61M |
| Castle Biosciences, Inc. | 1.190B |
| Vistagen Therapeutics, Inc. | 27.71M |
| Ocugen, Inc. | 587.16M |
Market Cap Related Metrics
| PEG Ratio | -0.116 |
| Price to Book Value | 2.640 |
| Price | 9.16 |
| Earnings Yield | -40.62% |
| PEGY Ratio | -0.116 |